雜志介紹

Cancer Drug Resistance雜志介紹

《Cancer Drug Resistance》是一本以English為主的未開放獲取國際優(yōu)秀期刊，中文名稱癌癥藥物耐藥性，本刊主要出版、報道領(lǐng)域的研究動態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進展，探討行業(yè)發(fā)展的思路和方法，以促進學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為4.6，最新CiteScore 指數(shù)為6.6。

英文介紹

Cancer Drug Resistance雜志英文介紹

Cancer Drug Resistance is an internationally peer-reviewed journal that focuses on the mechanisms of cancer drug resistance and strategies for overcoming them. This magazine is dedicated to publishing original research articles on the basic and translational studies of cancer cells developing tolerance to chemotherapy drugs, including molecular mechanisms, cell signaling pathways, drug design, and clinical treatment. The content of the magazine not only covers the resistance of traditional chemotherapy, but also the resistance mechanisms against targeted therapy and immunotherapy.

This journal provides a platform for the cancer research community to discuss the latest research findings, treatment strategies, and clinical trial results, with a particular focus on emerging treatment methods and technologies, such as the application of nanomedicine in improving drug efficacy and overcoming drug resistance. The magazine has promoted the scientific community's understanding of the complexity of cancer drug resistance and accelerated the development of new treatment methods by publishing high-quality research papers.